These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10886311)

  • 1. Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
    Sellebjerg F; Christiansen M; Jensen J; Frederiksen JL
    Eur J Neurol; 2000 May; 7(3):281-9. PubMed ID: 10886311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial.
    Rolak LA; Beck RW; Paty DW; Tourtellotte WW; Whitaker JN; Rudick RA
    Neurology; 1996 Feb; 46(2):368-72. PubMed ID: 8614496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.
    Sellebjerg F; Jensen CV; Larsson HB; Frederiksen JL
    Mult Scler; 2003 Feb; 9(1):102-7. PubMed ID: 12617276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid.
    Söderström M; Link H; Sun JB; Fredrikson S; Wang ZY; Huang WX
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):544-51. PubMed ID: 7515411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.
    Sørensen TL; Sellebjerg F; Jensen CV; Strieter RM; Ransohoff RM
    Eur J Neurol; 2001 Nov; 8(6):665-72. PubMed ID: 11784351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulse therapy in the treatment of optic neuritis in multiple sclerosis].
    Neroev VV; Karlova IZ; Guseva MR; Zaĭtseva OV; Boĭko SIu; Sidorenko EI; Dubovskaia LA; Budzinskaia MV; Boĭko AN
    Vestn Oftalmol; 2003; 119(5):28-31. PubMed ID: 14598491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis.
    Wang HY; Matsui M; Araya S; Onai N; Matsushima K; Saida T
    J Neurol Sci; 2003 Dec; 216(1):61-6. PubMed ID: 14607304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial.
    Trobe JD
    Arch Ophthalmol; 1994 Jan; 112(1):35-6. PubMed ID: 8285889
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients.
    Dufour A; Salmaggi A; La Mantia L; Eoli M; Nespolo A; Milanese C
    Int J Neurosci; 1994 Mar; 75(1-2):119-28. PubMed ID: 7914185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute axonal damage predicts clinical outcome in patients with multiple sclerosis.
    Lim ET; Sellebjerg F; Jensen CV; Altmann DR; Grant D; Keir G; Thompson EJ; Giovannoni G
    Mult Scler; 2005 Oct; 11(5):532-6. PubMed ID: 16193890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
    Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
    Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis.
    Sellebjerg F
    Dan Med Bull; 2004 May; 51(2):167-83. PubMed ID: 16009055
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in the management of optic neuritis.
    Kortvelesy S
    Hawaii Med J; 1997 Oct; 56(10):281. PubMed ID: 9385746
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR
    N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group.
    Beck RW; Trobe JD
    J Neuroophthalmol; 1995 Sep; 15(3):131-5. PubMed ID: 8574355
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.
    La Mantia L; Eoli M; Milanese C; Salmaggi A; Dufour A; Torri V
    Eur Neurol; 1994; 34(4):199-203. PubMed ID: 7915989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of restriction of T cell receptor beta variable gene usage in cerebrospinal fluid lymphocytes in acute optic neuritis.
    Heard RN; Teutsch SM; Bennetts BH; Lee SD; Deane EM; Stewart GJ
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):585-90. PubMed ID: 10519862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.